Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in pemphigus

American Journal of Pathology

Volumn 167, Issue 6, 2005, Pages 1531-1544

  Arredondo, Juan ^a   Chernyavsky, Alexander I ^a   Karaouni, Ali ^a   Grando, Sergei A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM ION; CALPAIN; CALPASTATIN; CASPASE 3; CASPASE 3 INHIBITOR; CASPASE 8; FAS LIGAND; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA;

ACANTHOLYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; BULLOUS SKIN DISEASE; CALCIUM CELL LEVEL; CELL DEATH; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LETHALITY; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; TARGET CELL;

EID: 28244492845     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61239-4     Document Type: Article

References (94)

1. Udey MC, Stanley JR: Pemphigus: diseases of antidesmosomal autoimmunity. J Am Med Assoc 1999, 282:572-576
2. Grande SA: Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 2000, 201:290-295
3. Korman NJ: Pemphigus. Dermatol Clin 8:689-700, 1990
4. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA: Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004, 279:2135-2146
5. Lever WF: Pemphigus and Pemphigoid. Springfield, Charles C Thomas, 1965
6. Judd KP, Lever WF: Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol 1979, 115:428-432
7. Sison-Fonacier L, Bystryn JC: Heterogeneity of pemphigus vulgaris antigens. Arch Dermatol 1987, 123:1507-1510
8. Herbst A, Bystryn JC: Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000, 42:422-427
9. Gniadecki R, Jemec GB, Thomsen BM, Hansen M: Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch Dermatol Res 1998, 290:528-532
10. Puviani M, Marconi A, Cozzani E, Pincelli C: Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J Invest Dermatol 2003, 120:164-167
11. Pelacho B, Natal C, Espana A, Sanchez-Carpintero I, Iraburu MJ, Lopez-Zabalza MJ: Pemphigus vuigaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett 2004, 566:6-10
12. Milner Y, Metezeau P, Kiefer H, Finemesser M, Bregegere F, Zlotkin M, Wang X, Michel B: Pemphigus an autoimmune disease of the skin: cell-cell separation versus membrane signaling and apoptosis in acantholysis. The Decade of Autoimmunity. Edited by Y Shoenfeld. Amsterdam, Elsevier Science BV, 1999, pp 606-615
13. Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y: Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004, 9:131-143
14. Wang X, Bregegere F, Soroka Y, Frusic-Zlotkin M, Milner Y: Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes. FEBS Lett 2004, 567:281-286
15. Grando SA, Chernyavsky AI, Arredondo J: Ability to induce keratinocyte apoptosis determines pathogenicity of pemphigus IgGs (abstract 35). J Investig Dermatol 2004, 122:A6
16. Frusic-Zlotkin M, Pergamentz R, Michel B, David M, Mimouni D, Bregegere F, Milner Y: The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann NY Acad Sci 2005, 1050:371-379
17. Ahmed AR: Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001, 45:679-690
18. Bystryn JC, Jiao D, Natow S: Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermatol 2002, 47:358-363
19. Bhol KC, Desai A, Kumari S, Colon JE, Ahmed AR: Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production. Clin Immunol 2001, 100:172-180
20. Prasad NK, Papoff G, Zeuner A, Bonnin E, Kazatchkine MD, Ruberti G, Kaveri SV: Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 1998, 161:3781-3790
21. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998, 282:490-493
22. Ekberg C, Nordstrom E, Skansen-Saphir U, Mansouri M, Raqib R, Sundqvist VA, Fernandez C: Human polyspecific immunoglobulin for therapeutic use induces p21/WAF-1 and Bcl-2, which may be responsible for G1 arrest and long-term survival. Hum Immunol 2001, 62:215-227
23. Stangel M, Schumacher HC, Ruprecht K, Boegner F, Marx P: Immunoglobulins for intravenous use inhibit TNF alpha cytotoxicity in vitro. Immunol Invest 1997, 26:569-578
24. Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Brocker EB, Blaser K, Akdis CA: Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001, 108:839-846
25. Spahn JD, Leung DY, Chan MT, Szefler SJ, Gelfand EW: Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 1999, 103:421-426
26. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195
27. Grando SA, Grando AA, Glukhenky BT, Doguzov V, Nguyen VT, Holubar K: History and clinical significance of mechanical symptoms in blistering dermatoses: a reappraisal. J Am Acad Dermatol 2003, 48:86-92
28. Grando SA, Kist DA, Qi M, Dahl MV: Human keratinocytes synthesize, secrete and degrade acetylcholine. J Invest Dermatol 1993, 101:32-36
29. Nguyen VT, Chernyavsky AI, Arredondo J, Bercovich D, Orr-Urtreger A, Vetter DE, Wess J, Beaudet AL, Kitajima Y, Grando SA: Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004, 294:534-549
30. Nguyen VT, Arredondo J, Chernyavsky AI, Pittelkow MR, Kitajima Y, Grando SA: Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. Arch Dermatol 2004, 140:327-334
31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
32. Bleche I, Onody P, Laurendeau I, Olivi M, Vidaud D, Lidereau R, Vidaud M: Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 1999, 45:1148-1156
33. Bleche I, Parfait B, Le Doussal V, Olivi M, Rio MC, Lidereau R, Vidaud M: Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy. Cancer Res 2001, 61:1652-1658
34. Arredondo J, Chernyavsky AI, Marubio LM, Beaudet AL, Jolkovsky DL, Pinkerton KE, Grando SA: Receptor-mediated tobacco toxicity: regulation of gene expression through a3b2 nicotinic receptor in oral epithelial cells. Am J Pathol 2005, 166:597-613
35. Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193
36. Gibson UE Held CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 1996, 6:995-1001
37. Arredondo J, Nguyen VT, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA: A receptor-mediated mechanism of nicotine toxicity in oral keratinocytes. Lab Invest 2001, 81:1653-1668
38. Majno G, Joris I: Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995, 146:3-15
39. Trump BF, Berezesky IK, Chang SH, Phelps PC: The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 1997, 25:82-88
40. Porter AG, Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999, 6:99-104
41. Liu X, Van Vleet T, Schnellmann RG: The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol 2004, 44:349-370
42. Shi Y, Melnikov VY, Schrier RW, Edelstein CL: Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol 2000, 279:F509-F517
43. Blomgren K, Hallin U, Andersson AL, Puka-Sundvall M, Bahr BA, McRae A, Saido TC, Kawashima S, Hagberg H: Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem 1999, 274:14046-14052
44. Chandrashekhar Y, Sen S, Anway R, Shuros A, Anand I: Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-1 cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 2004, 43:295-301
45. Cracker SJ, Smith PD, Jackson-Lewis V, Lamba WR, Hayley SP, Grimm E, Callaghan SM, Slack RS, Melloni E, Przedborski S, Robertson GS, Anisman H, Merali Z, Park DS: Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 2003, 23:4081-4091
46. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, Mallard C, Hagberg H: Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 2001, 276:10191-10198
47. Baroni A, Buommino E, Paoletti I, Orlando M, Ruocco E, Ruocco V: Pemphigus serum and captopril induce heat shock protein 70 and inducible nitric oxide synthase overexpression, triggering apoptosis in human keratinocytes. Br J Dermatol 2004, 150:1070-1080
48. Hockenbery D: Defining apoptosis. Am J Pathol 1995, 146:16-19
49. Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626
50. Wilgram GF, Caulfield JB, Lever WF: An electron microscopic study of acantholysis in pemphigus vulgaris. J Invest Dermatol 1961, 36:373-382
51. Fritsch PO, Elias PM: Mechanisms of vesicle formation and classification. Dermatology in General Medicine. Edited by TB Fitzpatrick, AZ Eisen, K Wolff, IM Freedberg, KF Austen. New York, McGraw-Hill Book Company, 1979, pp 287-295
52. Torsuyev NA, Sheklakov ND, Romanenko VN: Bullous Dermatoses. Moscow, Meditzina, 1979 (In Russian)
53. McKee PH: Pathology of the Skin: With Clinical Correlations. London, Mosby-Wolfe, 1996
54. Cohen LM, Skopicki DK, Harrist TJ, Clark WH Jr: A Noninfectious vesicobullous and vesicopustular diseases. Lever's Histopathology of the Skin, Edited by D Elder, R Elenitas, C Jaworsky, BJ Johnson. Philadelphia, Lippincott-Raven, 1997, pp 209-252
55. Sheklakov ND: Pemphigus. Moscow, MEDGIZ, 1961 (In Russian)
56. Collins RJ, Harmon BV, Gobe GC, Kerr JF: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 1992, 61:451-453
57. Aronchik I, Behne MJ, Leypoldt L, Crumrine D, Epstein E, Ikeda S, Mizoguchi M, Bench G, Pozzan T, Mauro T: Actin reorganization is abnormal and cellular ATP is decreased in Hailey-Hailey keratinocytes. J Invest Dermatol 2003, 121:681-687
58. Takeda M, Shirato I, Kobayashi M, Endou H: Hydrogen peroxide induces necrosis, apoptosis, oncosis and apoptotic oncosis of mouse terminal proximal straight tubule cells. Nephron 1999, 81:234-238
59. Tzank A: Le cytodiagnostic immediat en dermatologie. Ann Derm Syph 1948, 8:205
60. You KR, Shin MN, Park RK, Lee SO, Kim DG: Activation of caspase-8 during N-(4-hydroxyphenyl)retinamide-induced apoptosis in Fas-defective hepatoma cells. Hepatology 2001, 34:1119-1127
61. Gomez-Vicente V, Donovan M, Cotter TG: Multiple death pathways in retina-derived 661W cells following growth factor deprivation: crosstalk between caspases and calpains. Cell Death Differ 2005, 12:796-804
62. Chua BT, Guo K, Li P: Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem 2000, 275:5131-5135
63. Croall DE, DeMartino GN: Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 1991, 71:813-847
64. Glading A, Chang P, Lauffenburger DA, Wells A: Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem 2000, 275:2390-2398
65. 2+ signalling. Israel J Med Sci 1995, 31:42-48
66. Seishima M, Esaki C, Osada K, Mort S, Hashimoto T, Kitajima Y: Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995, 104:33-37
67. Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y: Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995, 105:329-333
68. Osada K, Seishima M, Kitajima Y: Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/ cytoskeleton fractions in human keratinocytes. J Invest Dermatol 1997, 108:482-487
69. Aoyama Y, Owada MK, Kitajima Y: A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 1999, 29:2233-2240
70. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS: Desmosome signaling: inhibition of p38MAPK prevents pemphigus vulgaris IgG induced cytoskeleton reorganization. J Biol Chem 2005, 280:23778-23784
71. Sanchez-Carpintero I, Espana A, Pelacho B, Lopez Moratalla N, Rubenstein DS, Diaz LA, Lopez-Zabalza MJ: In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol 2004, 151:565-570
72. Chang I, Cho N, Kim S, Kim JY, Kim E, Woo JE, Nam JH, Kim SJ, Lee MS: Role of calcium in pancreatic islet cell death by IFN-gamma/TNF-alpha. J Immunol 2004, 172:7008-7014
73. Ujihara M, Hamanaka S, Matsuda S, Numa F, Kato H: Pemphigus vulgaris associated with autoimmune hemolytic anemia and elevated TNF alpha. J Dermatol 1994, 21:56-58
74. Alecu M, Alecu S, Coman G, Galatescu E, Ursaciuc C: ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients. Roum Arch Microbiol Immunol 1999, 58:121-130
75. Ameglio F, D'Auria L, Cordiali-Fei P, Trento E, D'Agosto G, Mastroianni A, Giannetti A, Giacalone B: Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age. J Biol Regul Homeost Agents 1999, 13:220-224
76. D'Auria L, Bonifati C, Mussi A, D'Agosto G, De Simone C, Giacalone B, Ferraro C, Ameglio F: Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur Cytokine Netw 1997, 8:383-387
77. Lopez-Robles E, Avalos-Diaz E, Vega-Memije E, Hojyo-Tomoka T, Villalobos R, Fraire S, Domiguez-Soto L, Herrera-Esparza R: TNF-alpha and IL-6 are mediators in the blistering process of pemphigus. Int J Dermatol 2001, 40:185-188
78. Feliciani C, Toto P, Amerio P, Mohammad S, Coscione PS, Amerio P, Shivji G, Wang B, Sauder SN: In vitro and in vivo expression of interleukin-1a and tumor necrosis factor-a mRNA in pemphigus vulgaris: interleukin-1a and tumor necrosis factor-a are involved in acantholysis. J Invest Dermatol 2000, 114:71-77
79. Feliciani C, Toto P, Wang B, Sauder DN, Amerio P, Tulli A: Urokinase plasminogen activator mRNA is induced by IL-1 alpha and TNF-alpha in in vitro acantholysis. Exp Dermatol 2003, 12:466-471
80. Berookhim B, Fischer HD, Weinberg JM: Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept. Cutis 2004, 74:245-247
81. Lin MH, Hsu CK, Lee JY: Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser. Arch Dermatol 2005, 141:680-682
82. Harriman JF, Liu XL, Aleo MD, Machaca K, Schnellmann RG: Endoplasmic reticulum Ca(2+) signaling and calpains mediate renal cell death. Cell Death Differ 2002, 9:734-741
83. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998, 17:1675-1687
84. Grossmann J: Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 2002, 7:247-260
85. Aoudjit F, Vuori K: Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-FLIP and implications for anoikis. J Cell Biol 2001, 152:633-643
86. Sato N, Fujio Y, Yamada-Honda F, Funai H, Wada A, Kawashima S, Awata N, Shibata N: Elevated calcium level induces calcium-dependent proteolysis of A-CAM (N-cadherin) in heart-analysis by detergent-treated model. Biochem Biophys Res Commun 1995, 217:649-653
87. Miyachi Y, Yoshimura N, Suzuki S, Hamakubo T, Kannagi R, Imamura S, Murachi T: Biochemical demonstration and immunohistochemical localization of calpain in human skin. J Invest Dermatol 1986, 86:346-349
88. Ruocco V, Pisani M: Induced pemphigus. Arch Dermatol Res 1982, 274:123-140
89. Reis VM, Toledo RP, Lopez A, Diaz LA, Martins JE: UVB-induced acantholysis in endemic Pemphigus foliaceus (Fogo selvagem) and Pemphigus vulgaris. J Am Acad Dermatol 2000, 42:571-576
90. Ruiz-Vela A, Gonzalez de Buitrago G, Martinez AC: Implication of calpain in caspase activation during B cell clonal deletion. EMBO J 1999, 18:4988-4998
91. Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L, Allen H: Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis Arch Biochem Biophys 1998, 356:187-196
92. Brancolini C, Sgorbissa A, Schneider C: Proteolytic processing of the adherens junctions components beta-catenin and gamma-catenin/plakoglobin during apoptosis. Cell Death Differ 1998, 5:1042-1050
93. Steinhusen U, Badock V, Bauer A, Behrens J, Wittman-Liebold B, Dorken B, Bommert K: Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem 2000, 275: 16345-16353
94. Weiske J, Schoneberg T, Schroder W, Hatzfeld M, Tauber R, Huber O: The fate of desmosomal proteins in apoptotic cells. J Biol Chem 2001, 276:41175-41181